scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1044899772 |
P356 | DOI | 10.1186/1742-4690-10-86 |
P932 | PMC publication ID | 3751525 |
P698 | PubMed publication ID | 23938024 |
P5875 | ResearchGate publication ID | 255788760 |
P50 | author | Patrick Provost | Q37392016 |
John C. Burnett | Q50421173 | ||
P2093 | author name string | John J Rossi | |
Isabelle Plante | |||
Lise-Andrée Gobeil | |||
Dominique L Ouellet | |||
Jimmy Vigneault-Edwards | |||
Kevin Létourneau | |||
P2860 | cites work | Principles of microRNA-target recognition | Q21146368 |
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression | Q21245193 | ||
Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization | Q22009996 | ||
Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element | Q22242847 | ||
The association of Aiolos transcription factor and Bcl-xL is involved in the control of apoptosis | Q24291916 | ||
Genome-scale RNAi screen for host factors required for HIV replication | Q79769455 | ||
The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype | Q24299527 | ||
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs | Q24299641 | ||
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing | Q24306121 | ||
Protein B23 is an important human factor for the nucleolar localization of the human immunodeficiency virus protein Tat | Q24311873 | ||
Ribonuclease activity and RNA binding of recombinant human Dicer | Q24315047 | ||
The Drosha-DGCR8 complex in primary microRNA processing | Q24318603 | ||
Architecture and secondary structure of an entire HIV-1 RNA genome | Q24498349 | ||
Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP | Q24539076 | ||
Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element | Q24603188 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Upregulation of Cyclin B1 by miRNA and its implications in cancer | Q24630059 | ||
Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis | Q24630462 | ||
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus | Q24646050 | ||
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival | Q24649032 | ||
miR-34a repression of SIRT1 regulates apoptosis | Q24652720 | ||
Small dsRNAs induce transcriptional activation in human cells | Q24676787 | ||
HIV-1 encoded candidate micro-RNAs and their cellular targets | Q24802189 | ||
HIV-1 nef suppression by virally encoded microRNA | Q24803620 | ||
Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
Argonaute2 is the catalytic engine of mammalian RNAi | Q27860545 | ||
Role for a bidentate ribonuclease in the initiation step of RNA interference | Q27860832 | ||
Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs | Q28115922 | ||
Identification of virus-encoded microRNAs | Q28259309 | ||
Involvement of AGO1 and AGO2 in mammalian transcriptional silencing | Q28260436 | ||
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing | Q28280424 | ||
Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA | Q28290390 | ||
Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication | Q29616375 | ||
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE | Q29619356 | ||
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation | Q29620799 | ||
HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR | Q33292464 | ||
Current knowledge of MicroRNAs and noncoding RNAs in virus-infected cells | Q34003311 | ||
Existence of a microRNA pathway in anucleate platelets | Q34025954 | ||
Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology | Q34079023 | ||
Apoptosis in AIDS. | Q34230620 | ||
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis | Q34633003 | ||
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. | Q34985945 | ||
Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo | Q35914355 | ||
Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. | Q35980749 | ||
microRNAs associated with the different human Argonaute proteins | Q36341483 | ||
Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection | Q36554643 | ||
Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties | Q36678555 | ||
Microprocessor, Setx, Xrn2, and Rrp6 co-operate to induce premature termination of transcription by RNAPII. | Q36679818 | ||
Mechanisms of CD4 T-cell depletion triggered by HIV-1 viral proteins | Q36706549 | ||
High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states | Q37210511 | ||
Non-apoptotic functions of caspase-8. | Q37257608 | ||
Dynamic host energetics and cytoskeletal proteomes in human immunodeficiency virus type 1-infected human primary CD4 cells: analysis by multiplexed label-free mass spectrometry | Q37333959 | ||
Revisiting the principles of microRNA target recognition and mode of action | Q37368876 | ||
Analysis of the roles of HIV-derived microRNAs | Q37816443 | ||
Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. | Q37833502 | ||
The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity | Q37863312 | ||
Host factors mediating HIV-1 replication | Q37922877 | ||
HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation | Q39505749 | ||
Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. | Q39551717 | ||
The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle | Q39582195 | ||
Ikaros is degraded by proteasome-dependent mechanism in the early phase of apoptosis induction | Q39590376 | ||
Differential aiolos expression in human hematopoietic subpopulations. | Q39835670 | ||
HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. | Q39919699 | ||
Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts | Q40066451 | ||
Suppression of microRNA-silencing pathway by HIV-1 during virus replication | Q40166750 | ||
Structure and function of the human immunodeficiency virus leader RNA. | Q41080184 | ||
Molecule of the month: miRNA and HIV-1 TAR. | Q41815888 | ||
NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation | Q42128724 | ||
Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. | Q43786792 | ||
Structural and functional characterization of the human immunodeficiency virus rev protein. | Q45843914 | ||
Tat trans-activates the human immunodeficiency virus through a nascent RNA target | Q45847022 | ||
HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism | Q46780265 | ||
Ikaros increases normal apoptosis in adult erythroid cells | Q46862617 | ||
P921 | main subject | HIV | Q15787 |
microRNA | Q310899 | ||
P304 | page(s) | 86 | |
P577 | publication date | 2013-08-12 | |
P1433 | published in | Retrovirology | Q15793508 |
P1476 | title | Regulation of host gene expression by HIV-1 TAR microRNAs | |
P478 | volume | 10 |
Q33556837 | A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region |
Q52671487 | Are microRNAs Important Players in HIV-1 Infection? An Update. |
Q36230686 | Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA. |
Q91689685 | Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies |
Q37713982 | Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. |
Q59350860 | HIV infection alters the human epigenetic landscape |
Q33863026 | Human immunodeficiency virus Tat associates with a specific set of cellular RNAs |
Q90643326 | MicroRNA Involvement in Signaling Pathways During Viral Infection |
Q49236374 | Non-coding RNAs and retroviruses. |
Q34142030 | Novel HIV-1 miRNAs stimulate TNFα release in human macrophages via TLR8 signaling pathway |
Q91804744 | On the generation of the MSD-Ѱ class of defective HIV proviruses |
Q26748918 | Pathogens Use and Abuse MicroRNAs to Deceive the Immune System |
Q39627600 | RNAa Induced by TATA Box-Targeting MicroRNAs |
Q39914513 | Tat-dependent production of an HIV-1 TAR-encoded miRNA-like small RNA. |
Q84957624 | The Interplay Between Viral-Derived miRNAs and Host Immunity During Infection |
Q39292502 | The Role of HCMV and HIV-1 MicroRNAs: Processing, and Mechanisms of Action during Viral Infection |
Q53175931 | The Role of miRNAs in Virus-Mediated Oncogenesis. |
Q30377278 | The emerging role of long non-coding RNAs in HIV infection. |
Q36202761 | Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells |
Q40951472 | Two cellular microRNAs, miR-196b and miR-1290, contribute to HIV-1 latency |
Q38907008 | miR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4(+) T lymphocytes |
Search more.